The copyright wars are set to continue, with the government releasing a Productivity Commission report arguing for a relaxation of intellectual property laws.
Articles on Patents
Displaying 81 - 100 of 126 articles
The outgoing president leaves behind some solid accomplishments in the world of science, tech and medicine. But the biggest departure from his predecessors might have been in his approach.
The ruling in the Apple-Samsung case is ambiguous, ensuring the case will drag on for years more, potentially even ending up back in the Supreme Court.
If the UK is so intent on a ‘hard Brexit’, why did it just ratify a court that gives the EU jurisdiction over patent disputes?
The Supreme Court is considering two cases stemming from the merger of design and function that could reshape intellectual property law. Can we protect innovation without impeding fair competition?
Australia has never been short of inventors, scientists aren’t always at home in the ruthless world of commerce. But if they can be given a helping hand, it could help the entire economy.
Design patents cover how products look – but how much does appearance contribute to profits?
Why drug maker Mylan’s decision to introduce a half-price version of its EpiPen could be more than a publicity stunt.
Google saves $9 billion, programmers and users get to keep a popular language and its apps – and a key Oracle product stays alive.
The Productivity Commission’s report into copyright reform will be good for the public, good for innovation and good for Australia.
U.C. Berkeley and the Broad Institute are fighting to control the patents on the revolutionary gene-editing technology. But there’s a lot more at stake than just who gets the credit and licensing fees.
How scientists and corporations are plundering the developing world for new substances.
Motorola brought to market many features of mobile phones we take for granted, but it wasn’t enough.
Copyright law had to figure out how to deal with digital media. Now 3D printers – and their capacity for infringement – are poised to challenge the patent system in a similar way.
There is a window of opportunity for the least developed countries to develop their own pharmaceuticals industry.
Unless African governments put their money where their mouths are, innovative advances from young scientists on the continent will be stifled.
Intellectual property laws, 19th-century legislation struggling for relevance in the 21st century, are well overdue for reform.
Intellectual property is critical to Australia’s success, but we don’t need another review to tell us where the problems are.
An important sticking point in TTIP negotiations has US and European representatives fighting over food labels.
The generic drug industry has become essential to developing countries that need access to cheaper drugs to treat their heavy burdens of communicable diseases.
Top contributors
-
Professor of Intellectual Property Law, City St George's, University of London
-
Associate Professor, School of Law, University of Canberra
-
Professor of Public Health, La Trobe University
-
Assistant Professor of Resource Economics, UMass Amherst
-
Professor of Law, University of Denver
-
Associate Professor of Public Policy and Women's Studies, University of Michigan
-
DST-NRF SARChI Chair in Innovation Studies, Tshwane University of Technology
-
Lecturer, Faculty of Law, Monash University
-
Tshwane University of Technology
-
Professor of Economics, Loughborough University
-
Associate Professor of Law, Fordham University
-
Professor and Distinguished Research Chair, Globalization and Health Equity, L’Université d’Ottawa/University of Ottawa
-
John M. Thompson Chair in Information Technology and Innovation and Professor, Western University
-
Senior Lecturer in Law, City St George's, University of London
-
Director, Melbourne Institute of Applied Economic and Social Research, The University of Melbourne